Mackenzie Financial’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Sell |
6,069,301
-44,321
| -0.7% | -$107K | 0.02% | 418 |
|
|
2025
Q1 | $13.5M | Sell |
6,113,622
-69,094
| -1% | -$153K | 0.02% | 412 |
|
|
2024
Q4 | $33.7M | Sell |
6,182,716
-180,696
| -3% | -$985K | 0.05% | 265 |
|
|
2024
Q3 | $52.9M | Buy |
6,363,412
+502,771
| +9% | +$4.18M | 0.07% | 218 |
|
|
2024
Q2 | $42M | Buy |
5,860,641
+844,325
| +17% | +$6.05M | 0.06% | 236 |
|
|
2024
Q1 | $43.5M | Sell |
5,016,316
-152,860
| -3% | -$1.33M | 0.06% | 234 |
|
|
2023
Q4 | $33.9M | Buy |
5,169,176
+238,335
| +5% | +$1.56M | 0.05% | 258 |
|
|
2023
Q3 | $48.7M | Buy |
4,930,841
+1,384,455
| +39% | +$13.7M | 0.08% | 195 |
|
|
2023
Q2 | $44.1M | Buy |
3,546,386
+1,008,824
| +40% | +$12.5M | 0.07% | 227 |
|
|
2023
Q1 | $35.6M | Buy |
2,537,562
+416,401
| +20% | +$5.83M | 0.05% | 259 |
|
|
2022
Q4 | $30.4M | Buy |
2,121,161
+2,070,193
| +4,062% | +$29.6M | 0.05% | 267 |
|
|
2022
Q3 | $1.3M | Buy |
+50,968
| New | +$1.3M | ﹤0.01% | 778 |
|